Saxagliptin, also known as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. .
Dong, Jizhe; Gong, Yanchun; Liu, Jun; Chen, Xiangfeng; Wen, Xiaoan; Sun, Hongbin. Synthesis and biological evaluation of all eight stereoisomers of DPP-IV inhibitor saxagliptin. Bioorganic & Medicinal Chemistry. Volume 22. Issue 4. Pages 1383-1393. 2014.
Sharma, Padam N.; Galvin, Gabriel M.; Boettger, Susan D.; Racha, Saibaba; Zhu, Jingyang; Melton, Jack; Mudryk, Boguslaw M. Ammonolysis process for the preparation of intermediates for pyrrolidine-based dipeptidyl peptidase IV inhibitors. 2006.
Henryon, Vivien; Monbrun, Jerome; Casado, Michel. Method for preparation of adamantyl compounds starting from adamantoyl chloride. Assignee Finorga, Fr. WO 2010032129. (2010).
Bhirud, Shekhar Bhaskar; Bhushan, Kumar Hari; Swamy, H. M. Veerabhadra; Patil, Dilipkumar J. Preparation of saxagliptin and hydrates. Assignee Glenmark Generics Limited, India. IN 2012MU01883. (2014).
Tran, Scott B.; Maxwell, Brad D.; Cao, Kai; Bonacorsi, Samuel J. The synthesis of 14C-labeled, 13CD2-labeled saxagliptin, and its 13CD2-labeled 5-hydroxy metabolite. Journal of Labelled Compounds and Radiopharmaceuticals. Volume 57. Issue 3. Pages 136-140. 2014.
Rajan, Srinivasan Thirumalai; Eswaraiah, Sajja; Reddy, Ghojala Venkat. Process for the preparation of DPP-IV inhibitor (1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile. Assignee MSN Laboratories Limited, India. WO 2013111158. (2013).
Patil, Madhukar; Patel, Mahesh; Punde, Dnyandeo; Wagh, Ghanshyam; Gadakar, Mahesh Kumar; Gore, Vinayak. Preparation of a saxagliptin intermediate. Assignee Mylan Laboratories Ltd., India. IN 2011CH04203. (2013).
Ratkaj, Marina; Biljan, Tomislav; Marinkovic, Marina. Processes for preparation of saxagliptin Schiff bases and saxagliptin polymorphs. Assignee Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA, Inc. WO 2011140328. (2011).
Marinkovic, Marina; Ratkaj, Marina; Frankovic, Oliver; Mundorfer, Tina. Preparation of polymorphs of saxagliptin hydrochloride. Assignee Teva Pharmaceutical Industries Ltd., Israel. US 20120083517. (2012).
Lee, Byeong Seok; Shin, Sang Hun; Ahn, Yu Gil; Chun, Eun Jeong. Method for the preparation of saxagliptin and synthetic intermediate thereof. Assignee Kyungdong Pharmaceutical Co., Ltd., S. Korea. KR 1715682. (2017).
